March 12, 2026 Experience Integer Holdings cooperation agreement with Irenic Capital Management We are advising Integer on its cooperation agreement with Irenic Capital
March 4, 2026 Experience One Call acquisition of Data Dimensions We are advising One Call on the transaction
February 19, 2026 Experience Coloplast acquisition of Uromedica We are advising Coloplast on the transaction
February 13, 2026 Experience Rhône Capital acquisition of Invacare We advised Highbridge Capital, as an Invacare secured lender and noteholder, on the transaction
January 21, 2026 Experience LXO Group hybrid capital acquisition financing We advised Hayfin Capital Management on its hybrid capital investment in LXO Group
January 15, 2026 Experience Penumbra $14.5 billion sale to Boston Scientific We are advising Penumbra on the transaction
January 5, 2026 Experience W. L. Gore & Associates acquisition of Conformal Medical We are advising Gore on the transaction
December 16, 2025 Experience LifeScan emerges from chapter 11 We advised an ad hoc group of secured lenders in connection with LifeScan’s chapter 11 proceedings
October 30, 2025 Experience Novo Nordisk proposed $9.1 billion acquisition of Metsera We are advising Novo Nordisk on the transaction
September 30, 2025 Experience Amulet Capital Partners sale of SSI Strategy to Clinigen We are advising Amulet Capital Partners and SSI Strategy on the sale